Efficacy of green tea in the prevention of cancers

Nursing and Health Sciences

Volumn 11, Issue 4, 2009, Pages 436-446

  Sturgeon, Jenna L ^a   Williams, Mary ^a   van Servellen, Gwen ^b  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Cancer risk; Cancer treatment; Green tea; Literature review; Prevention

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; EPIGALLOCATECHIN; GREEN TEA EXTRACT; PLACEBO; POLYPHENOL; POLYPHENON E;

BLOOD TOXICITY; BREAST CANCER; CANCER PREVENTION; CANCER RECURRENCE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC GASTRITIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; CONFUSION; DIARRHEA; DIET SUPPLEMENTATION; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; ESOPHAGUS CANCER; GASTRIC DYSMOTILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTENSION; INTESTINAL DYSMOTILITY; LUNG CANCER; MAXIMUM TOLERATED DOSE; MOUTH CANCER; NAUSEA; PANCREAS CANCER; PATIENT COMPLIANCE; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RECTUM CANCER; REVIEW; RISK REDUCTION; STOMACH CANCER; SURVIVAL RATE; SYSTEMATIC REVIEW; T CELL LEUKEMIA; TEA; UTERINE CERVICITIS; UTERINE CERVIX DYSPLASIA;

ADULT; AGED; ANTICARCINOGENIC AGENTS; ASIA; BEVERAGES; COMPLEMENTARY THERAPIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RISK; TEA;

EID: 70449564529     PISSN: 14410745     EISSN: 14422018     Source Type: Journal    
DOI: 10.1111/j.1442-2018.2009.00476.x     Document Type: Review

References (40)

1. Ahn W-S, Yoo J, Huh S-W. Protective effects of green tea extracts (polyphenon e and EGCG) on human cervical lesions. Eur. J. Cancer Prev. 2003, 12:383-390.
2. Cancer Facts and Figures - 2008. 2008a, http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf, American Cancer Society (ACS), Cited 25 Mar 2009.] Available from URL:
3. ACS: Herbs, Vitamins, and Minerals. 2008b, http://www.cancer.org/docroot/eto/eto_5_2_5.asp, American Cancer Society (ACS), Cited 11 Oct 2008.] Available from URL:
4. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 2006, 66:1234-1240.
5. Choan E, Segal R, Jonker D. A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach. Urol. Oncol. 2005, 23:108-113.
6. Hoshiyama Y, Kawaguchi T, Miura Y. A prospective study of stomach cancer death in relation to green tea consumption in Japan. Br. J. Cancer 2002, 87:309-313.
7. Hoshiyama Y, Kawaguchi T, Miura Y. A nested case-control study of stomach cancer in relation to green tea consumption in Japan. Br. J. Cancer 2004, 90:135-138.
8. Ide R, Fujino Y, Hoshiyama Y. A prospective study of green tea consumption and oral cancer incidence in Japan. Ann. Epidemiol. 2007, 17:821-826.
9. Inoue M, Robien K, Wang R, Van Den Berg DJ, Koh W-P, Yu MC. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008, 29:1967-1972.
10. Inoue M, Tajima K, Mizutani M. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 2001, 167:175-182.
11. Jatoi A, Ellison N, Burch PA. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003, 97:1442-1446.
12. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: A case-control study in southeast China. Int. J. Cancer 2004, 108:130-135.
13. Kikuchi N, Ohmori K, Shimazu T. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br. J. Cancer 2006, 95:371-373.
14. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am. J. Epidemiol. 2008, 167:71-77.
15. Kuriyama S, Shimazu T, Ohmori K. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA 2006, 296:1255-1265.
16. Lambert JD, Hong J, Yang G-Y, Liao J, Yang CS. Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr. 2005, 81:284S-291S.
17. Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother. Pharmacol. 2005, 55:33-38.
18. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 2004, 104:788-794.
19. Luo J, Inoue M, Iwasaki M. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur. J. Cancer Prev. 2007, 16:542-548.
20. Melnyk BM, Fineout-Overholt E, Melnyk BM, Fineout-Overholt E. Steps one and two: Getting started. Evidence-based Practice in Nursing and Healthcare: A Guide to Best Practice 2004, 10. In, eds, New York, Lippincott Williams & Wilkins
21. Mu L-N, Lu Q-Y, Yu S-Z. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int. J. Cancer 2005, 116:972-983.
22. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 2001, 12:501-508.
23. National Cancer Institute Fact Sheet: Tea and Cancer Prevention. 2002, http://www.cancer.gov/cancertopics/factsheet/tea-and-cancer-prevention/print?page=&key, National Cancer Institute (NCI), Cited 15 Jul 2008.] Available from URL:
24. Pisters KMW, Newman RA, Coldman B. Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 2001, 19:1830-1838.
25. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J. Clin. Oncol. 2007, 18:2505-2514.
26. Sasazuki S, Inoue M, Hanaoka T, Yamamoto S, Sobue T, Tsugane S. Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study. Cancer Causes Control 2004, 15:483-491.
27. Seely D, Mills EJ, Verma S, Guyatt GH. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr. Cancer Ther. 2005, 4:144-155.
28. Setiawan VW, Zhang Z-F, Yu G-P. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer 2001, 92:600-604.
29. Sonoda J, Koriyama C, Yamamoto S. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci. 2004, 95:596-601.
30. Sun C-L, Yuan J-M, Koh W-P, Lee H-P, Yu MC. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2007, 28:2143-2148.
31. Tsubono Y, Nishino Y, Komatsu S. Green tea and the risk of gastric cancer in Japan. N. Engl. J. Med. 2001, 244:632-636.
32. Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur. J. Gastroenterol. Hepatol. 2007, 19:171-176.
33. Wang LD, Zhou Q, Feng CW. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high incidence area for esophageal cancer. Jpn. J. Cancer Chemother. 2002, 29:159-170.
34. Global Cancer Rates Could Increase by 50% to 15 million by 2020. 2003, http://www.who.int/mediacentre/news/releases/2003/pr27/en/print.html, World Health Organization (WHO), Cited 13 Nov 2008.] Available from URL:
35. Wu AH, Yu MC, Tseng C-C, Hankin J, Pike MC. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 2003, 106:574-579.
36. Yang G, Shu X-O, Li H. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1219-1223.
37. Yuan J-M, Koh W-P, Sun C-L, Lee H-P, Yu MC. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26:1389-1394.
38. Zhang M, Holman CDAJ, Huang J-P, Xie X. Green tea and the prevention of breast cancer: a case control study in southeast China. Carcinogenesis 2007, 28:1074-1078.
39. Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int. J. Cancer 2004, 112:465-469.
40. Zhong L, Goldberg MS, Gao Y-T, Hanley JA, Parent M-E, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001, 12:695-700.